Comparing efficacy and safety between Naldebain® and intravenous patient-controlled analgesia with fentanyl for pain management post-laparotomy: study protocol for a randomized controlled, non-inferior trial

[1] Chou R(2016)Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anethesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council J Pain 17 131-157

[2] Gordon DB(2017)Lidocaine/ketorolac-loaded biodegradable nanofibrous anti-adhesive membranes that offer sustained pain relief for surgical wounds Int J Nanomedicine 12 5893-5901

[3] de Leon-Casasola OA(2013)Postoperative pain control Clin Colon Rectal Surg 26 191-196

[4] Rosenberg JM(2014)Drug-induced impairment of renal function Int J Nephrol Renovasc Dis 7 457-468

[5] Bickler S(2017)Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended-release formulation Biopharm Drug Dispos 38 494-497

[6] Brennan T(2017)In vitro and in vivo release of dinalbuphine sebacate extended release formulation: effect of the oil ratio on drug release Int J Pharm 531 306-312

[7] Kao CW(2017)Sebacoyl dinalbuphine ester extended-release injection for long-acting analgesia Clin J Pain 33 429-434

[8] Lee D(2009)Ambulatory surgery in the United States, 2006 Natl Health Stat Report 28 1-25

[9] Wu MH(2010)National hospital discharge survey: 2007 summary Natl Health Stat Report 29 1-20

[10] Chen JK(2003)Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged Anesth Analg 97 534-540

[1] Chou R(2016)Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anethesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council J Pain 17 131-157

[2] Gordon DB(2017)Lidocaine/ketorolac-loaded biodegradable nanofibrous anti-adhesive membranes that offer sustained pain relief for surgical wounds Int J Nanomedicine 12 5893-5901

[3] de Leon-Casasola OA(2013)Postoperative pain control Clin Colon Rectal Surg 26 191-196

[4] Rosenberg JM(2014)Drug-induced impairment of renal function Int J Nephrol Renovasc Dis 7 457-468

[5] Bickler S(2017)Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended-release formulation Biopharm Drug Dispos 38 494-497

[6] Brennan T(2017)In vitro and in vivo release of dinalbuphine sebacate extended release formulation: effect of the oil ratio on drug release Int J Pharm 531 306-312

[7] Kao CW(2017)Sebacoyl dinalbuphine ester extended-release injection for long-acting analgesia Clin J Pain 33 429-434

[8] Lee D(2009)Ambulatory surgery in the United States, 2006 Natl Health Stat Report 28 1-25

[9] Wu MH(2010)National hospital discharge survey: 2007 summary Natl Health Stat Report 29 1-20

[10] Chen JK(2003)Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged Anesth Analg 97 534-540